c-LEcta announces the signing of an amendment of a framework supply agreement with one of the world’s TOP 10 pharma companies. It expands the long lasting relation between the companies by the supply of 4 additional enzyme products developed and produced by c-LEcta within the supply agreement.
Over the years, c-LEcta has developed itself from a technology provider to a leading supplier of enzymes for industrial applications in highly regulated markets. Especially the pharmaceutical industry with its high quality standards nowadays is one of the main pillars of c-LEcta’s business providing high quality products.
This very successful cooperation with the undisclosed pharma company now lasts for around 10 years and led to a large number of new enzymatic production processes in the value chain of c-LEcta’s pharma customer. The current execution of the contract is an important milestone in the business relation of c-LEcta with this pharma company.
Over the years, c-LEcta has developed itself from a technology provider to a leading supplier of enzymes for industrial applications in highly regulated markets. Especially the pharmaceutical industry with its high quality standards nowadays is one of the main pillars of c-LEcta’s business providing high quality products.
This very successful cooperation with the undisclosed pharma company now lasts for around 10 years and led to a large number of new enzymatic production processes in the value chain of c-LEcta’s pharma customer. The current execution of the contract is an important milestone in the business relation of c-LEcta with this pharma company.
